Global Information
회사소개 | 문의

비만 수술 기기 : 의료기기 파이프라인 평가

Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2018

리서치사 GlobalData
발행일 2018년 08월 상품 코드 408137
페이지 정보 영문 168 Pages
가격
US $ 4,000 ₩ 4,592,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,000 ₩ 9,184,000 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 12,000 ₩ 13,776,000 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


비만 수술 기기 : 의료기기 파이프라인 평가 Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2018
발행일: 2018년 08월 페이지 정보 : 영문 168 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계 비만 수술 기기(Bariatric Surgery Devices) 시장의 주요 파이프라인 제품(의료기기)과 임상시험 진행 상황에 대해 조사했으며, 제품 특성 비교 분석(임상시험 진행 단계별), 주요 기업 개요 및 대표적 제품, 최근 시장 동향(자본거래 및 사업 제휴 등) 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 비만 수술 기기 개요

제3장 현재 임상시험 중인 제품

  • 파이프라인 제품 : 임상시험 단계별
  • 파이프라인 제품 : 부문별
  • 파이프라인 제품 : 영역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증 시기별
  • 현재 진행중인 임상시험

제4장 비만 수술 기기 : 각 기업에서 현재 임상시험 중인 파이프라인 제품

  • 비만 수술 기기 기업 : 임상시험 단계별 파이프라인 제품
  • 비만 수술 기기 : 임상시험 단계별 파이프라인 제품

제5장 비만 수술 기기 기업 및 제품 개요

  • 3DT Holdings, LLC
    • 파이프라인 제품 및 진행중인 임상시험 개요
  • Allurion Technologies, Inc.
  • Applied Medical Resources Corporation
  • BAROnova, Inc.
  • BFKW, LLC
  • Boston Scientific Corp
  • C. R. Bard Inc
  • Columbia University
  • Crospon Ltd
  • EndoRetics Inc.
  • EndoVx Inc
  • Gelesis Inc
  • GI Dynamics Inc
  • Hebrew University of Jerusalem
  • Innovia LLC
  • John Hopkins University
  • Lotus, Ltd.
  • Mayo Clinic US
  • Medi-Globe GmbH
  • MetaModix, Inc
  • Mmtc, Inc.
  • National University of Singapore
  • Obalon Therapeutics Inc
  • Onciomed, Inc.
  • Precision Medical Devices, Inc.
  • Satiety Inc
  • Sensate LLC
  • Silhouette Medical, Inc.
  • SLIMEDICS LTD
  • FGIA, Inc
  • Standard Bariatrics, Inc.
  • Surefire Medical Inc
  • SynerZ Medical, Inc.
  • TransEnterix, Inc.
  • Tulip Medical Ltd.
  • LifeSciences LLC
  • University of Florida
  • University of Miami
  • ValenTx, Inc.
  • Vancive Medical Technologies
  • Vibrynt, Inc.

제6장 비만 수술 기기 시장 : 최근 동향

제7장 부록

도표

LSH 16.12.26

1.1 List of Tables

  • Table 1: Bariatric Surgery Devices - Pipeline Products by Stage of Development 11
  • Table 2: Bariatric Surgery Devices - Pipeline Products by Segment 12
  • Table 3: Bariatric Surgery Devices - Pipeline Products by Territory 13
  • Table 4: Bariatric Surgery Devices - Pipeline Products by Regulatory Path 14
  • Table 5: Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date 15
  • Table 6: Bariatric Surgery Devices - Ongoing Clinical Trials 16
  • Table 7: Bariatric Surgery Devices Companies - Pipeline Products by Stage of Development 17
  • Table 8: Bariatric Surgery Devices - Pipeline Products by Stage of Development 19
  • Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 10: Gastric Sleeve Magnetic Implant - Product Status 21
  • Table 11: Gastric Sleeve Magnetic Implant - Product Description 21
  • Table 12: Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 13: Elipse Balloon - Product Status 22
  • Table 14: Elipse Balloon - Product Description 22
  • Table 15: Allurion Technologies, Inc. - Ongoing Clinical Trials Overview 23
  • Table 16: Elipse Balloon - A Randomized, Multi-center, Phased, Pivotal Safety and Efficacy Study Comparing the Elipse Gastric Balloon System Versus Sham for the Treatment of Obese Adults 24
  • Table 17: Elipse Balloon - Pilot Trial of the Elipse Intragastric Balloon System for the Treatment of Overweight and Obese Individuals 24
  • Table 18: Elipse Balloon - The BALLOON- (Balloon Treatment for Obesity in Norway) Pilot Study 24
  • Table 19: Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 20: Next Generation Bariatric Surgical Device - Product Status 25
  • Table 21: Next Generation Bariatric Surgical Device - Product Description 25
  • Table 22: BAROnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 23: TransPyloric Shuttle Device - Product Status 26
  • Table 24: TransPyloric Shuttle Device - Product Description 26
  • Table 25: BFKW, LLC Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 26: Full Sense - Product Status 27
  • Table 27: Full Sense - Product Description 27
  • Table 28: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 29: TERIS - Product Status 28
  • Table 30: TERIS - Product Description 28
  • Table 31: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 32: Restore Suturing System - Product Status 29
  • Table 33: Restore Suturing System - Product Description 29
  • Table 34: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 35: Gastric Bypass Shunt - Product Status 30
  • Table 36: Gastric Bypass Shunt - Product Description 30
  • Table 37: EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 38: Endoretics Device - Product Status 31
  • Table 39: Endoretics Device - Product Description 31
  • Table 40: EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 41: EndoVx Device - Product Status 32
  • Table 42: EndoVx Device - Product Description 32
  • Table 43: Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 44: Gelesis100 - Product Status 33
  • Table 45: Gelesis100 - Product Description 33
  • Table 46: Gelesis100 - Pediatric - Product Status 34
  • Table 47: Gelesis100 - Pediatric - Product Description 34
  • Table 48: GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 49: EndoBarrier Flow Restrictor - Product Status 35
  • Table 50: EndoBarrier Flow Restrictor - Product Description 35
  • Table 51: EndoBarrier Liner With EndoBarrier Restrictor - Product Status 36
  • Table 52: EndoBarrier Liner With EndoBarrier Restrictor - Product Description 36
  • Table 53: GI Dynamics Inc - Ongoing Clinical Trials Overview 37
  • Table 54: EndoBarrier Liner With EndoBarrier Restrictor - Endoscopic Treatment of Obesity with a Duodenal-jejunal Bypass Sleeve: Does Impairment of Fat Absorption Explain Weight Loss 38
  • Table 55: EndoBarrier Liner With EndoBarrier Restrictor - Randomization to Endoluminal Intestinal Liner Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity) 38
  • Table 56: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 57: MetaboShield - Product Status 39
  • Table 58: MetaboShield - Product Description 39
  • Table 59: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 60: Gastric Balloon - Product Status 40
  • Table 61: Gastric Balloon - Product Description 40
  • Table 62: Gastric Sleeve - Product Status 41
  • Table 63: Gastric Sleeve - Product Description 41
  • Table 64: Laparoscopic Band - Product Status 41
  • Table 65: Laparoscopic Band - Product Description 41
  • Table 66: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 67: Image-guided Bariatric Arterial Embolization Device - Product Status 42
  • Table 68: Image-guided Bariatric Arterial Embolization Device - Product Description 42
  • Table 69: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 70: Endoscopic Therapy Device - Obesity - Product Status 43
  • Table 71: Endoscopic Therapy Device - Obesity - Product Description 43
  • Table 72: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 73: Medi-Globe Gastric Balloon - Product Status 44
  • Table 74: Medi-Globe Gastric Balloon - Product Description 44
  • Table 75: MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 76: Endosleeve - Product Status 45
  • Table 77: Endosleeve - Product Description 45
  • Table 78: Second Generation Liner Device - Product Status 46
  • Table 79: Second Generation Liner Device - Product Description 46
  • Table 80: Mmtc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 81: Wearable BAT Monitor - Product Status 47
  • Table 82: Wearable BAT Monitor - Product Description 47
  • Table 83: Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 84: Gastric Clip - Product Status 48
  • Table 85: Gastric Clip - Product Description 48
  • Table 86: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 87: Weight Management Device - Product Status 49
  • Table 88: Weight Management Device - Product Description 49
  • Table 89: Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 90: Flow Control Device - Obesity - Product Status 50
  • Table 91: Flow Control Device - Obesity - Product Description 50
  • Table 92: ReShape Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 93: ReShape Vest - Product Status 51
  • Table 94: ReShape Vest - Product Description 51
  • Table 95: ReShape Lifesciences Inc - Ongoing Clinical Trials Overview 52
  • Table 96: ReShape Vest - Safety and Performance Study for the Gastric Vest System: Gastric Vest CE Mark trial 53
  • Table 97: Satiety Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 98: TOGA System - Product Status 54
  • Table 99: TOGA System - Product Description 54
  • Table 100: Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 101: Sensate Anchored Gastric Device - Product Status 55
  • Table 102: Sensate Anchored Gastric Device - Product Description 55
  • Table 103: Silhouette Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 104: nObese Device - Product Status 56
  • Table 105: nObese Device - Product Description 56

1.2 List of Figures

  • Figure 1: Bariatric Surgery Devices - Pipeline Products by Stage of Development 11
  • Figure 2: Bariatric Surgery Devices - Pipeline Products by Segment 12
  • Figure 3: Bariatric Surgery Devices - Pipeline Products by Territory 13
  • Figure 4: Bariatric Surgery Devices - Pipeline Products by Regulatory Path 14
  • Figure 5: Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date 15
  • Figure 6: Bariatric Surgery Devices - Ongoing Clinical Trials 16

영문목차

GlobalData's Medical Devices sector report, "Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Bariatric Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bariatric Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bariatric Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bariatric Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bariatric Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Bariatric Surgery Devices Overview 9

3 Products under Development 10

  • 3.1 Bariatric Surgery Devices - Pipeline Products by Stage of Development 10
  • 3.2 Bariatric Surgery Devices - Pipeline Products by Segment 11
  • 3.3 Bariatric Surgery Devices - Pipeline Products by Territory 12
  • 3.4 Bariatric Surgery Devices - Pipeline Products by Regulatory Path 13
  • 3.5 Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date 14
  • 3.6 Bariatric Surgery Devices - Ongoing Clinical Trials 15

4 Bariatric Surgery Devices - Pipeline Products under Development by Companies 16

  • 4.1 Bariatric Surgery Devices Companies - Pipeline Products by Stage of Development 16
  • 4.2 Bariatric Surgery Devices - Pipeline Products by Stage of Development 18

5 Bariatric Surgery Devices Companies and Product Overview 20

  • 5.1 3DT Holdings LLC Company Overview 20
  • 5.2 Allurion Technologies, Inc. Company Overview 21
  • 5.3 Applied Medical Resources Corporation Company Overview 24
  • 5.4 BAROnova, Inc. Company Overview 25
  • 5.5 BFKW, LLC Company Overview 26
  • 5.6 Boston Scientific Corp Company Overview 27
  • 5.7 C. R. Bard Inc Company Overview 28
  • 5.8 Columbia University Company Overview 29
  • 5.9 EndoRetics Inc. Company Overview 30
  • 5.10 EndoVx Inc Company Overview 31
  • 5.11 Gelesis Inc Company Overview 32
  • 5.12 GI Dynamics Inc Company Overview 34
  • 5.13 Hebrew University of Jerusalem Company Overview 38
  • 5.14 Innovia LLC Company Overview 39
  • 5.15 Johns Hopkins University Company Overview 41
  • 5.16 Mayo Clinic Company Overview 42
  • 5.17 Medi-Globe GmbH Company Overview 43
  • 5.18 MetaModix, Inc Company Overview 44
  • 5.19 Mmtc, Inc. Company Overview 46
  • 5.20 Nanyang Technological University Company Overview 47
  • 5.21 National University of Singapore Company Overview 48
  • 5.22 Precision Medical Devices Inc Company Overview 49
  • 5.23 ReShape Lifesciences Inc Company Overview 50
  • 5.24 Satiety Inc (Inactive) Company Overview 53
  • 5.25 Sensate LLC Company Overview 54
  • 5.26 Silhouette Medical, Inc. Company Overview 55
  • 5.27 SLIMEDICS LTD Company Overview 56
  • 5.28 Spatz FGIA, Inc Company Overview 57
  • 5.29 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview 58
  • 5.30 TransEnterix Inc Company Overview 59
  • 5.31 Tulip Medical Ltd. Company Overview 60
  • 5.32 UAS LifeSciences LLC Company Overview 61
  • 5.33 University of Florida Company Overview 62
  • 5.34 University of Miami Company Overview 63
  • 5.35 ValenTx, Inc. Company Overview 64
  • 5.36 Vibrynt, Inc. (Inactive) Company Overview 67

6 Bariatric Surgery Devices- Recent Developments 68

  • 6.1 Jul 17, 2018: BAROnova Announces Submission of Premarket Approval Application to the U.S. FDA for the TransPyloric Shuttle Device Intended for the Treatment of Obesity 68
  • 6.2 Jul 16, 2018: Surefire Medical Names Anil Singhal As Board Director 68
  • 6.3 Jul 04, 2018: NHS EndoBarrier Service Shows Patients Maintain Treatment Effect Six Months Post Explant 69
  • 6.4 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 70
  • 6.5 Jun 27, 2018: ReShape Lifesciences Announces Acceptance of Abstract to be Presented at IFSO Annual Conference 71
  • 6.6 Jun 19, 2018: ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest 71
  • 6.7 Jun 06, 2018: FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon 71
  • 6.8 Jun 05, 2018: Harry Leider, Former Chief Medical Officer of Walgreens, Joins Gelesis as Chief Medical Officer, and Paul Fonteyne, Chairman and Former CEO of Boehringer Ingelheim USA, Joins the Gelesis Board of Directors 72
  • 6.9 Jun 05, 2018: Apollo Endosurgery Announces Presentation of Mayo Clinic's Clinical Study of ORBERA Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis at Digestive Disease Week 2018 73
  • 6.10 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 75
  • 6.11 Jun 04, 2018: Apollo Endosurgery Announces FDA Approval of Revised Labeling for the ORBERA Intragastric Balloon System 76
  • 6.12 Jun 04, 2018: Apollo Endosurgery Announces Presentation of Intragastric Balloon Comparison Study at Digestive Disease Week 2018 titled: "Fluid-Filled Intragastric Balloons are Superior to Gas-Filled Balloon" 77

7 Appendix 164

  • 7.1 Methodology 164
  • 7.2 About GlobalData 167
  • 7.3 Contact Us 167
  • 7.4 Disclaimer 167
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research